Back-to-Back Nights of Racing for Reed in Kentucky

SPARTA, Ky. (September 23, 2015) – Roush Fenway Racing driver Ryan Reed returns to Kentucky Speedway this weekend for back-to-back nights of racing. On Friday night, Reed will drive the No. 38 Lilly Diabetes Lira Motorsports Ford Fusion in the ARCA Racing Series presented by Menards.  On Saturday, he will return back to the track to race his No. 16 Lilly Diabetes American Diabetes Association Ford Mustang in the NASCAR XFINITY Series event.

Friday marks Reed’s second ARCA Racing Series start of the season. In June, Reed won the ARCA Racing Series SCOTT 150 at Chicagoland Speedway behind the wheel of the No. 58 machine for Lira Motorsports.

He will also compete in the ARCA Racing Series event at Kansas Speedway in October for Lira Motorsports.

American Muscle

“I’m thrilled to be back behind the wheel of the No. 38 machine for Lira Motorsports for two more races,” said Reed. “I know Carlos (Lira) and (crew chief) Teddy Brown will give me an awesome car to drive and hopefully we can bring home another victory for the team.”

Reed is slated to complete 300 miles at the 1.5-mile oval between the two races at Kentucky Speedway. Members of his Roush Fenway Racing pit crew will also pull double-duty, performing over-the-wall duties for both races.

Reed has three previous starts in the NASCAR XFINITY Series at Kentucky Speedway with his highest finish of 11th coming in September 2014.

“Kentucky can be really tough to maneuver with the track’s bumps and your on-throttle time,” said Reed. “We found some good things during the race in July that we can hit on for this upcoming race and I know (crew chief) Chad (Norris) has been working on a lot of things to try out as well. I had an ARCA test there yesterday so I had some extra track time and am really excited to get back on track in our XFINITY Series car on Friday.”

Reed will start the weekend off with an ARCA Racing Series practice on Friday afternoon followed by NASCAR XFINITY Series practice. The ARCA Racing Series will qualify at 4:40 p.m. on Friday, followed by NASCAR XFINITY Series final practice.

The ARCA Racing Series Crosley Brands 150 from Kentucky Speedway will be televised live on Fox Sports 1 on Friday, September 25 at 8 p.m. ET.

The following night, Reed will return to the driver’s seat of the No. 16 Lilly Diabetes American Diabetes Association Ford Mustang for the NASCAR XFINITY Series 300 at 8 p.m. ET. The race will air live on NBC Sports Network and PRN.

Roush Fenway Racing is the winningest team in NASCAR history, fielding multiple teams in NASCAR Sprint Cup Series and NASCAR XFINITY Series competition with drivers Greg Biffle, Ricky Stenhouse Jr., Trevor Bayne, Elliott Sadler, Ryan Reed, Chris Buescher and Bubba Wallace. Now in its 28th season, Roush Fenway is a leader in driver development, having launched the careers for many of the top drivers in the sport. Off-track, Roush Fenway is a leader in NASCAR marketing solutions, pioneering motorsport’s first team-focused TV show and producing multiple award-winning digital and experiential marketing campaigns. Roush Fenway is co-owned by Jack Roush, the winningest team owner in NASCAR history and Fenway Sports Group, parent company of Major League Baseball’s Boston Red Sox and English Premier League’s Liverpool F.C. Visit, circle on Google+, become a fan on Facebook and Instagram and follow on Twitter at @roushfenway.

About the American Diabetes Association

The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit Information from both these sources is available in English and Spanish.

About Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit or follow us on Twitter: @LillyDiabetes.

Get 2 FREE stocks valued between $2.50-$1,400 when you open and fund a Webull brokerage account or earn 5% annual interest rate at Worthy.
The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of


Please enter your comment!
Please enter your name here